Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Sodium-glucose Transporter Type 2 Inhibition in Anthracycline-related Cardiotoxicity	Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder	Recruiting	Not applicable	2026-04-30		NCT07070765

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
NHS Grampian	18
University of Aberdeen	37

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Cardiac Research Office, Aberdeen Royal Infirmary	Aberdeen	United Kingdom	4
University of Aberdeen	Aberdeen	United Kingdom	3

Clinical trials